Neuregulin-1β as a potential therapeutic for targeting fibroblasts in heart disease

Neuregulin-1β as a potential therapeutic for targeting fibroblasts in heart disease

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular and cellular cardiology 2017-11, Vol.112, p.132-133
1. Verfasser: Gardner, Jason D.
Format: Artikel
Sprache:eng
Schlagworte:
Animals
Fibroblasts - metabolism
Fibroblasts - pathology
Heart Diseases - drug therapy
Humans
Myocardium - pathology
Neuregulin-1 - administration & dosage
Neuregulin-1 - therapeutic use
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 133
container_issue
container_start_page 132
container_title Journal of molecular and cellular cardiology
container_volume 112
creator Gardner, Jason D.
description
doi_str_mv 10.1016/j.yjmcc.2017.07.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1917665029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022282817301293</els_id><sourcerecordid>1917665029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c359t-7c141ebf70aa50ea4d8480a51d65535699636c6b825037912740a18fd52ba87d3</originalsourceid><addsrcrecordid>eNp9kMFq3DAQhkVpaLZJnqBQdOzFm5FsydKhhxKStBCSS3IWY3m8q8VrbyW5sK-VB8kzxdtNewz8MDB8__zMz9gXAUsBQl9ulvvN1vulBFEvYRbID2whwKrCKFN9ZIt5IwtppDlln1PaAICtyvITO5VGGwugFuzxnqZIq6kPQyFenjkmjnw3ZhpywJ7nNUXc0ZSD590Yeca4ohyGFe9CE8emx5QTDwNfE8bM25AIE52zkw77RBdv84w93Vw_Xv0s7h5uf139uCt8qWwuai8qQU1XA6ICwqo1lQFUotVKlUpbq0vtdWOkgrK2QtYVoDBdq2SDpm7LM_bteHcXx98Tpey2IXnqexxonJITVtRaK5B2Rssj6uOYUqTO7WLYYtw7Ae5Qp9u4v3W6Q50OZoGcXV_fAqZmS-1_z7_-ZuD7EaD5zT-Boks-0OCpDZF8du0Y3g14BUVvh2w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1917665029</pqid></control><display><type>article</type><title>Neuregulin-1β as a potential therapeutic for targeting fibroblasts in heart disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Gardner, Jason D.</creator><creatorcontrib>Gardner, Jason D.</creatorcontrib><identifier>ISSN: 0022-2828</identifier><identifier>EISSN: 1095-8584</identifier><identifier>DOI: 10.1016/j.yjmcc.2017.07.002</identifier><identifier>PMID: 28689005</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Fibroblasts - metabolism ; Fibroblasts - pathology ; Heart Diseases - drug therapy ; Humans ; Myocardium - pathology ; Neuregulin-1 - administration &amp; dosage ; Neuregulin-1 - therapeutic use</subject><ispartof>Journal of molecular and cellular cardiology, 2017-11, Vol.112, p.132-133</ispartof><rights>2017 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c359t-7c141ebf70aa50ea4d8480a51d65535699636c6b825037912740a18fd52ba87d3</citedby><cites>FETCH-LOGICAL-c359t-7c141ebf70aa50ea4d8480a51d65535699636c6b825037912740a18fd52ba87d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.yjmcc.2017.07.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27926,27927,45997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28689005$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gardner, Jason D.</creatorcontrib><title>Neuregulin-1β as a potential therapeutic for targeting fibroblasts in heart disease</title><title>Journal of molecular and cellular cardiology</title><addtitle>J Mol Cell Cardiol</addtitle><subject>Animals</subject><subject>Fibroblasts - metabolism</subject><subject>Fibroblasts - pathology</subject><subject>Heart Diseases - drug therapy</subject><subject>Humans</subject><subject>Myocardium - pathology</subject><subject>Neuregulin-1 - administration &amp; dosage</subject><subject>Neuregulin-1 - therapeutic use</subject><issn>0022-2828</issn><issn>1095-8584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFq3DAQhkVpaLZJnqBQdOzFm5FsydKhhxKStBCSS3IWY3m8q8VrbyW5sK-VB8kzxdtNewz8MDB8__zMz9gXAUsBQl9ulvvN1vulBFEvYRbID2whwKrCKFN9ZIt5IwtppDlln1PaAICtyvITO5VGGwugFuzxnqZIq6kPQyFenjkmjnw3ZhpywJ7nNUXc0ZSD590Yeca4ohyGFe9CE8emx5QTDwNfE8bM25AIE52zkw77RBdv84w93Vw_Xv0s7h5uf139uCt8qWwuai8qQU1XA6ICwqo1lQFUotVKlUpbq0vtdWOkgrK2QtYVoDBdq2SDpm7LM_bteHcXx98Tpey2IXnqexxonJITVtRaK5B2Rssj6uOYUqTO7WLYYtw7Ae5Qp9u4v3W6Q50OZoGcXV_fAqZmS-1_z7_-ZuD7EaD5zT-Boks-0OCpDZF8du0Y3g14BUVvh2w</recordid><startdate>201711</startdate><enddate>201711</enddate><creator>Gardner, Jason D.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201711</creationdate><title>Neuregulin-1β as a potential therapeutic for targeting fibroblasts in heart disease</title><author>Gardner, Jason D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c359t-7c141ebf70aa50ea4d8480a51d65535699636c6b825037912740a18fd52ba87d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Fibroblasts - metabolism</topic><topic>Fibroblasts - pathology</topic><topic>Heart Diseases - drug therapy</topic><topic>Humans</topic><topic>Myocardium - pathology</topic><topic>Neuregulin-1 - administration &amp; dosage</topic><topic>Neuregulin-1 - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gardner, Jason D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of molecular and cellular cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gardner, Jason D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuregulin-1β as a potential therapeutic for targeting fibroblasts in heart disease</atitle><jtitle>Journal of molecular and cellular cardiology</jtitle><addtitle>J Mol Cell Cardiol</addtitle><date>2017-11</date><risdate>2017</risdate><volume>112</volume><spage>132</spage><epage>133</epage><pages>132-133</pages><issn>0022-2828</issn><eissn>1095-8584</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28689005</pmid><doi>10.1016/j.yjmcc.2017.07.002</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2828
ispartof Journal of molecular and cellular cardiology, 2017-11, Vol.112, p.132-133
issn 0022-2828
1095-8584
language eng
recordid cdi_proquest_miscellaneous_1917665029
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Fibroblasts - metabolism
Fibroblasts - pathology
Heart Diseases - drug therapy
Humans
Myocardium - pathology
Neuregulin-1 - administration & dosage
Neuregulin-1 - therapeutic use
title Neuregulin-1β as a potential therapeutic for targeting fibroblasts in heart disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T20%3A51%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuregulin-1%CE%B2%20as%20a%20potential%20therapeutic%20for%20targeting%20fibroblasts%20in%20heart%20disease&rft.jtitle=Journal%20of%20molecular%20and%20cellular%20cardiology&rft.au=Gardner,%20Jason%20D.&rft.date=2017-11&rft.volume=112&rft.spage=132&rft.epage=133&rft.pages=132-133&rft.issn=0022-2828&rft.eissn=1095-8584&rft_id=info:doi/10.1016/j.yjmcc.2017.07.002&rft_dat=%3Cproquest_cross%3E1917665029%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1917665029&rft_id=info:pmid/28689005&rft_els_id=S0022282817301293&rfr_iscdi=true